| HbA(1c) variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes. | |
| | |
MedLine Citation:
|
PMID: 23314044 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIMS/HYPOTHESIS: This study aimed to investigate whether variation in long-term glycaemia in type 1 diabetes as measured by HbA(1c) variability is associated with the cumulative incidence and risk of retinopathy requiring laser treatment. METHODS: The effect of HbA(1c) variability was assessed in 2,019 Finnish Diabetic Nephropathy (FinnDiane) study patients. The patients were studied in two partially overlapping subcohorts with either verified first laser treatment (n = 1,459) or retinopathy severity graded from ophthalmic records with the Early Treatment of Diabetic Retinopathy Study (ETDRS) scale (n = 1,346). The ratio of intrapersonal SD and mean of serially measured HbA(1c) was considered an estimate of HbA(1c) variability. RESULTS: A subcohort of 1,459 patients did not have laser treatment prior to the first FinnDiane visit and 174 of these patients were treated during a mean follow-up period of 5.2 ± 2.2 years. The 5 year cumulative incidence of laser treatment was 19% (95% CI 15, 24) in the highest quartile of HbA(1c) variability and 10% (95% CI 7, 12) in the lowest quartile (p < 0.001, Gray's test) with a corresponding HR of 1.6 (95% CI 1.1, 2.5; p = 0.02) adjusted for renal status, diabetes duration, mean HbA(1c), blood pressure, sex and number of HbA(1c) measurements. In a subcohort of 1,346 patients, 434 patients had proliferative diabetic retinopathy (PDR). Patients in the highest quartile of HbA(1c) variability had an increased risk of PDR compared with the lowest quartile (HR 1.7 [95% CI 1.3, 2.2]; p < 0.001]). CONCLUSIONS/INTERPRETATION: HbA(1c) variability was associated with an increased cumulative incidence and risk of retinopathy requiring laser treatment in type 1 diabetes. |
| | |
Authors:
|
K Hietala; J Wadén; C Forsblom; V Harjutsalo; J Kytö; P Summanen; P-H Groop; |
Related Documents
:
|
17686944 - Evidence of increased inflammation and microcirculatory abnormalities in patients with ... 15255124 - Current status of therapeutic plasma exchange in korea. 23248194 - Diabetes and risk of fracture-related hospitalization: the atherosclerosis risk in comm... 10871894 - Potential new treatments for type 2 diabetes. 1149774 - Hepatic balances of glucose and insulin in response to physiological increments of endo... 18838054 - The role of insulin analogs in type 2 diabetes in the rural community. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-13 |
Journal Detail:
|
Title: Diabetologia Volume: - ISSN: 1432-0428 ISO Abbreviation: Diabetologia Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0006777 Medline TA: Diabetologia Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Folkhälsan Institute of Genetics, Folkhälsan Research Centre, Biomedicum Helsinki, University of Helsinki, PO Box 63, Haartmaninkatu 8, FIN-00014, Helsinki, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of Iodonium-Class Flavin Dehydrogenase Inhibitors on Growth, Reactive Oxygen Production, Cel...
Next Document: Inhibition of protein glycation by urea and thiourea derivatives of glycine/proline conjugated benzi...